Camp4 Therapeutics Corporation
CAMPNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $185.95M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.90$7.75
- Volume (live)
- -
- Avg. volume (3M)
- 268.13K
Camp4 Therapeutics (CAMP) Stock Price & Financial Analysis
Camp4 Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.19 - $3.32 |
|---|---|
| 52-Week High | $7.75 |
| 52-Week Low | $2.90 |
| Open | $3.32 |
| Volume (last close) | 60.06K |
| Average Volume (3M) | 268.13K |
| Revenue (TTM) | 4.22M |
|---|---|
| Net Income (TTM) | -107.24M |
| Free Cash Flow (TTM) | -28.72M |
| EPS (TTM) | −$2.20 |
| Profit Margin | -2543.74% |
| Operating Margin | -1254.22% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 185.95M |
|---|---|
| Shares Outstanding | 57.93M |
| Price to Sales (P/S) | 45.34 |
| Price to Book (P/B) | -275.86 |
| EV/EBITDA | -2.22 |
| 50-Day MA | $4.08 |
|---|---|
| 200-Day MA | $4.32 |
| 1-Year Change | −2.59% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Camp4 Therapeutics at a Glance
As of the Oct 26, 2026 close, Camp4 Therapeutics (CAMP) has a market capitalization of $185.95M. The stock trades at 45.3× sales. Over the trailing twelve months it lost $107.24M on revenue of $4.22M and burned $28.72M of free cash flow. Revenue grew 40.2% year over year.
As of its latest reported balance sheet, it holds $86.40M in cash and securities against $2.37M of debt, a net cash position of $84.03M.
Camp4 Therapeutics does not currently pay a dividend.
The share price is down 2.6% over the past year. At $3.21 (the Oct 26, 2026 close) it sits near the bottom of its 52-week range of $2.90 to $7.75, below its 200-day moving average of $4.32.
Based on 7 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $8.80, 174.1% above the Oct 26, 2026 close.
Frequently Asked Questions About Camp4 Therapeutics
What is the current stock price for CAMP?
As of the Oct 26, 2026 close, CAMP stock trades at $3.21. The 52-week range is $2.90–$7.75, with a day range of $3.19–$3.32.
What is the P/E ratio for CAMP?
The P/E ratio (Price-to-Earnings) for CAMP is shown in the Key Statistics section. This valuation metric helps compare Camp4 Therapeutics Corporation to industry peers.
Does CAMP pay dividends?
Camp4 Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CAMP?
Based on ratings from 7 professional analysts over the last 90 days, the consensus for CAMP is Buy. The average 12-month price target is $8.80, a 174.1% upside from the Oct 26, 2026 close of $3.21.
What is the market cap of CAMP?
As of the Oct 26, 2026 close, Camp4 Therapeutics's market capitalization is $186.0M, classifying it as a micro-cap company. Camp4 Therapeutics operates in the Healthcare sector within the Biotechnology industry.